Author:
Perez Mike,Chang Chung-Che (Jeff)
Reference96 articles.
1. Jaffe ES, World Health Organization. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Myeloproliferative Neoplasms. 4th ed. Lyon/Oxford: IARC Press/Oxford University Press; 2008.
2. Jelinek J, Oki Y, Gharibyan V, et al. JAK2 mutation 1849G>T is rare in leukemia but can be found in CMML, Phildadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood. 2005;106:3370–3373.
3. Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood. 2005;106:2162–2168.
4. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779–1790.
5. Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387–397.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献